These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16430946

  • 1. The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.
    Eitan R, Soslow R, Lin O, Kauff ND, Liu L, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Aug; 102(2):315-8. PubMed ID: 16430946
    [Abstract] [Full Text] [Related]

  • 2. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 3. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

  • 4. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
    Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J.
    J Clin Oncol; 2005 Jan 01; 23(1):127-32. PubMed ID: 15625367
    [Abstract] [Full Text] [Related]

  • 5. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.
    Am J Surg Pathol; 2009 Jan 01; 33(1):111-9. PubMed ID: 18830124
    [Abstract] [Full Text] [Related]

  • 6. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K.
    N Engl J Med; 2002 May 23; 346(21):1609-15. PubMed ID: 12023992
    [Abstract] [Full Text] [Related]

  • 7. Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.
    Landon G, Stewart J, Deavers M, Lu K, Sneige N.
    Gynecol Oncol; 2012 Jun 23; 125(3):683-6. PubMed ID: 22425664
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
    Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ, van't Veer LJ.
    Br J Cancer; 2004 Apr 19; 90(8):1492-7. PubMed ID: 15083174
    [Abstract] [Full Text] [Related]

  • 9. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Büttner R, Ulrich U, Schmutzler RK.
    Arch Gynecol Obstet; 2011 Mar 19; 283(3):623-7. PubMed ID: 20428881
    [Abstract] [Full Text] [Related]

  • 10. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U.
    BJOG; 2011 Jun 19; 118(7):814-24. PubMed ID: 21392246
    [Abstract] [Full Text] [Related]

  • 11. The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.
    Blok F, Roes EM, van Leenders GJ, van Beekhuizen HJ.
    BMC Cancer; 2016 Jan 14; 16():18. PubMed ID: 26768420
    [Abstract] [Full Text] [Related]

  • 12. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
    Escobar PF, Starks DC, Fader AN, Barber M, Rojas-Espalliat L.
    Gynecol Oncol; 2010 Oct 14; 119(1):43-7. PubMed ID: 20579712
    [Abstract] [Full Text] [Related]

  • 13. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
    Reitsma W, de Bock GH, Oosterwijk JC, Bart J, Hollema H, Mourits MJ.
    Eur J Cancer; 2013 Jan 14; 49(1):132-41. PubMed ID: 22921157
    [Abstract] [Full Text] [Related]

  • 14. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM, Dørum A, Dahl AA.
    Gynecol Oncol; 2009 Apr 14; 113(1):128-33. PubMed ID: 19178933
    [Abstract] [Full Text] [Related]

  • 15. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
    Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Dec 14; 33(12):1878-85. PubMed ID: 19898224
    [Abstract] [Full Text] [Related]

  • 16. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
    Kauff ND, Barakat RR.
    J Clin Oncol; 2007 Jul 10; 25(20):2921-7. PubMed ID: 17617523
    [Abstract] [Full Text] [Related]

  • 17. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
    Miller H, Pipkin LS, Tung C, Hall TR, Masand RP, Anderson ML.
    J Minim Invasive Gynecol; 2017 Jul 10; 24(5):772-776. PubMed ID: 28285055
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.
    Garcia C, Lyon L, Conell C, Littell RD, Powell CB.
    Gynecol Oncol; 2015 Sep 10; 138(3):723-6. PubMed ID: 26086567
    [Abstract] [Full Text] [Related]

  • 19. Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery.
    Awtrey CS, Abu-Rustum NR, Disa JJ, Ivy JJ, Kauff ND, Hummer AJ, Barakat RR.
    Gynecol Oncol; 2005 Dec 10; 99(3):720-5. PubMed ID: 16169063
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.
    Obstet Gynecol; 2006 Sep 10; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.